Grifols SA GRFS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:51 PM EDT
7.01quote price arrow up+0.07 (+1.01%)
Volume
432,393
52 week range
5.30 - 12.15
Loading...
  • Open6.92
  • Day High7.03
  • Day Low6.92
  • Prev Close6.94
  • 52 Week High12.15
  • 52 Week High Date12/29/23
  • 52 Week Low5.30
  • 52 Week Low Date03/06/24

Key Stats

  • Market Cap4.82B
  • Shares Out687.55M
  • 10 Day Average Volume1.24M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change-39.27

KEY STATS

  • Open6.92
  • Day High7.03
  • Day Low6.92
  • Prev Close6.94
  • 52 Week High12.15
  • 52 Week High Date12/29/23
  • 52 Week Low5.30
  • 52 Week Low Date03/06/24
  • Market Cap4.82B
  • Shares Out687.55M
  • 10 Day Average Volume1.24M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change-39.27

RATIOS/PROFITABILITY

  • EPS (TTM)0.10
  • P/E (TTM)70.45
  • Fwd P/E (NTM)11.47
  • EBITDA (TTM)1.27B
  • ROE (TTM)0.99%
  • Revenue (TTM)7.107B
  • Gross Margin (TTM)37.84%
  • Net Margin (TTM)2.74%
  • Debt To Equity (MRQ)173.63%

EVENTS

  • Earnings Date05/14/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Grifols SA

 

Profile

MORE
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing...
Thomas Glanzmann
Chairman, Executive Director
Jose Ignacio Abia
Chief Executive Officer, Executive Director
Alfredo Arroyo Guerra
Chief Financial Officer
Miguel Angel Louzan Garcia
Chief Digital Information Officer
Address
C/ Jesus y Maria, 6
Barcelona, BAR
08022
Spain

Top Peers

SYMBOLLASTCHG%CHG
CRL
Charles River Laboratories International Inc
227.23-2.86-1.24%
INCY
Incyte Corp
53.12-0.38-0.71%
ILMN
Illumina Inc
110.85-0.50-0.45%
EXEL
Exelixis Inc
21.38-0.39-1.77%
PTCT
PTC Therapeutics Inc
32.15+1.10+3.53%